Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
Atlanta, GA 30341-3717
Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760
Submit a Question Online
These articles were published in the November 15, 2008 supplement edition of the journal Cancer, produced by the American Cancer Society, entitled "Assessing the Burden of HPV-Associated Cancers in the United States."
Balamurugan A, Ahmed F, Saraiya M Kosary C, Schwenn M, Cokkinides V, Flowers LC, Pollack LA. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 2008;113(S10):2919–2925.
Bates JH, Parikh-Patel A, Hofer BM. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 2008;113(S10):2955–2963.
Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, and Weir HK. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008;113(S10):2910–2918.
Castle P, Solomon D, Saslow D, Schiffman M. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States. Cancer 2008;113(S10):3031–3035.
Copeland G, Datta SD, Spivak G, Garvin AD, Cote M. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985–2003. Cancer 2008;113(S10):2946–2954.
Coughlin SS, Richards TB, Nasseri K, Weiss NS, Wiggins C, Saraiya M, Stinchcomb DG, Vensor V, Nielson C. Cervical cancer incidence in the United States in the US-Mexico border region, 1998–2003. Cancer 2008;113(S10):2964–2973.
Dunne EF, Datta SD, Markowitz L. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer 2008;113(S10):2995–3003.
Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis—United States, 2003. Cancer 2008;113(S10):2936–2945.
Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113(S10):3036–3046.
Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano AR, Goodman MT, King JB, Negoita S, Villalon-Gomez JM. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer 2008;113(S10):2883–2891.
Hopenhayn C, King JB, Christian A, Huang B, Christian WJ. Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer 2008;113(S10):2974–2980.
Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, Villalon-Gomez JM, Williams M, Cress RD. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008;113(S10):2892–2900.
Khan K, Curtis CR, Ekwueme DU, Stokley S, Walker C, Roland KB, Saraiya M. Preventing cervical cancer: Overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer 2008;113(S10):3004–3012.
Negoita S, Harrison JN, Qiao B, Ekwueme DU, Flowers LC, Kahn AR. Distribution of treatment for human papillomavirus-associated gynecologic carcinomas before prophylactic vaccine. Cancer 2008;113(S10):2926–2935.
Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 2008;113(S10):2901–2909.
Saraiya M, Ahmed F, White MC, Lawson H, Unger ER, Eheman CR. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US. Cancer 2008;113(S10):2837–2840.
Saraiya M, Goodman MT, Datta SD, Chen VW, Wingo P. Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: The potential role. Cancer 2008;113(S10):3047–3057.
Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Giuliano AR. Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer 2008;113(S10):2865–2872.
Tiro JA, Saraiya M, Jain N, Liddon N, Cokkinides V, Lai SM, Breen N, Wideroff L. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 2008;113(S10):3013–3030.
Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods. Cancer 2008;113(S10):2841–2854.
Watson M, Saraiya M, Benard V, Coughlin SS, Flowers LC, Cokkinides V, Schwenn M, Huang Y, Giuliano AR. Burden of cervical cancer in the United States, 1998–2003. Cancer 2008;113(S10):2855–2864.
Whiteside MA, Siegel EM, Unger ER. Human papillomavirus and molecular considerations for cancer risk. Cancer 2008;113(S10):2981–2994.
Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 2008;113(S10):2873–2882.
Other Relevant Research
Chesson HW, Ekwueme DU, Saraiya M, Markowitz LE. Cost-effectiveness of human papillomavirus vaccination in the United States. Emerging Infectious Diseases 2008;14(2):244–251.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2007;56(RR-2):1–24.
Page last reviewed: November 5, 2008
Page last updated: November 5, 2008
Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion